This live web event has ended. Thank you for attending.
Safety Surveillance through Antiretroviral Pregnancy Registry
- Describe the objectives of the Antiretroviral Pregnancy Registry (APR)
- List key findings from analysis of APR data
- Describe four steps to report a drug exposure to the APR
- Identify early warning signals of major tetrogenicity